Becton, Dickinson and Company
(NYSE : BDX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
1.30%76.120.8%$447.19m
MDTMedtronic PLC
1.23%93.750.6%$447.07m
ISRGIntuitive Surgical, Inc.
0.36%551.862.4%$409.76m
ALGNAlign Technology, Inc.
1.50%253.996.3%$360.12m
TMOThermo Fisher Scientific Inc.
0.25%252.081.0%$357.45m
BSXBoston Scientific Corporation
1.00%40.521.1%$310.41m
SYKStryker Corporation
0.60%188.701.3%$304.17m
BDXBecton, Dickinson and Company
0.78%249.621.1%$245.88m
BAXBaxter International Inc.
0.88%74.681.7%$204.04m
EWEdwards Lifesciences Corporation
-0.83%172.491.2%$200.76m
ABMDABIOMED, Inc.
-1.61%352.603.3%$188.18m
ZBHZimmer Biomet Holdings, Inc.
0.78%124.441.7%$170.74m
DXCMDexCom, Inc.
-6.42%136.868.5%$161.77m
WATWaters Corporation
0.34%235.373.5%$146.81m
IDXXIDEXX Laboratories, Inc.
1.55%209.183.7%$111.08m

Company Profile

Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences. The BD Medical segment produces medical devices that are used in healthcare settings. This segment product includes needles, syringes and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles for the self-injection of insulin and other drugs used in the treatment of diabetes. The BD Life Sciences segment produces products for the safe collection and transport of diagnostic specimens, as well as instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers. The segment also produces research and clinical tools that facilitate the study of cells, and the components of cells, to gain a better understanding of normal and disease processes. The principal products and services in the Life Sciences segment include integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing and tuberculosis culturing systems; molecular testing systems for infectious diseases and women's health; microorganism identification and drug susceptibility systems; liquid-based cytology systems for cervical cancer screening; rapid diagnostic assays; microbiology laboratory automation; plated media; fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; molecular indexing and next-generation sequencing sample preparation for genomics research; clinical oncology, immunology and transplantation diagnostic/monitoring reagents and analyzers; and cell culture media supplements for biopharmaceutical manufacturing. Becton, Dickinson & Co. was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.